Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of L-arginine in Severe Asthma Patients Grouped by Exhaled Nitric Oxide Level

NCT01841281 is registered in ClinicalTrials.gov with Nicholas Kenyon as lead sponsor.

NCT NCT01841281
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01841281 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of L-arginine in Severe Asthma Patients Grouped by Exhaled Nitric Oxide Level
Lead sponsor
Nicholas Kenyon
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2013
Completion date
December 31, 2019
Enrollment
54 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma, inflammation